LGALS9 and secondary progressive multiple sclerosis: Gal-9 has a dual role depending on the disease stage: it may exert an immunoregulatory effect during RRMS, whereas in the context of SPMS, its elevated levels are likely associated with sustained CNS inflammation and disease progression [16].